750 results
Keyword Paliperidone Teva Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Teva
cabazitaxel, Prostatic Neoplasms
Date of refusal: 11/07/2019, Refused, Last updated: 24/07/2019Cabazitaxel Teva Prostatic Neoplasms … Cabazitaxel Teva … Cabazitaxel Teva cabazitaxel cabazitaxel … -
List item
Human medicine European public assessment report (EPAR): Topotecan Teva
topotecan, Ovarian Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 21/09/2009,
, Revision: 8, Withdrawn, Last updated: 13/07/2018
Topotecan Teva Ovarian Neoplasms Uterine … Topotecan Teva … EMEA/H/C/1071 Topotecan Teva topotecan EPAR summary … -
List item
Human medicine European public assessment report (EPAR): Leflunomide Teva
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 10/03/2011,, Revision: 6, Withdrawn, Last updated: 18/03/2014
Leflunomide Teva Arthritis, Rheumatoid … Leflunomide Teva … Public statement Leflunomide Teva Cessation of validity of … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Teva
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 17/04/2009,, Revision: 4, Withdrawn, Last updated: 27/09/2012
Rivastigmine Teva Dementia Alzheimer Disease Parkinson … authorisation for Rivastigmine Teva has been withdrawn at the … Summary documents Rivastigmine Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Telmisartan Teva Pharma
telmisartan, Hypertension
Date of authorisation: 03/10/2011,, Revision: 10, Authorised, Last updated: 26/10/2021
Telmisartan Teva Pharma Cardiovascular Diseases Vascular … report (EPAR) for Telmisartan Teva Pharma. It explains how the … conditions of use for Telmisartan Teva Pharma. What is Telmisartan Teva Pharma? Telmisartan Teva Pharma is a medicine that … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 12, Authorised, Last updated: 24/11/2021
Pioglitazone Teva Nutritional and Metabolic … report (EPAR) for Pioglitazone Teva. It explains how the Committee … conditions of use for Pioglitazone Teva. What is Pioglitazone Teva? Pioglitazone Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Raloxifene Teva
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 29/04/2010,, Revision: 10, Authorised, Last updated: 27/09/2021
Raloxifene Teva Musculoskeletal Diseases Bone … Report (EPAR) for Raloxifene Teva. It explains how the Committee … conditions of use for Raloxifene Teva. What is Raloxifene Teva? Raloxifene Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva Pharma
docetaxel, Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Prostatic Neoplasms
Date of authorisation: 21/01/2011,, Revision: 6, Withdrawn, Last updated: 21/01/2014
Docetaxel Teva Pharma Carcinoma, Non-Small-Cell … Docetaxel Teva Pharma … ublic statement on Docetaxel Teva Pharma 7 Westferry … -
List item
Human medicine European public assessment report (EPAR): Dimethyl fumarate Teva
dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis
Date of authorisation: 12/12/2022,, Authorised, Last updated: 21/12/2022
Dimethyl fumarate Teva Nervous System Diseases Autoimmune … Overview Dimethyl fumarate Teva is a medicine used to treat … remissions). Dimethyl fumarate Teva is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Irbesartan/Hydrochlorothiazide Teva
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 26/11/2009,, Revision: 21, Authorised, Last updated: 31/08/2022
besartan/Hydrochlorothiazide Teva Cardiovascular Diseases Vascular … besartan/Hydrochlorothiazide Teva … besartan/Hydrochlorothiazide Teva irbesartan hydrochlorothiaz … -
List item
Human medicine European public assessment report (EPAR): Ibandronic Acid Teva
ibandronic acid, Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone; Osteoporosis, Postmenopausal
Date of authorisation: 17/09/2010,, Revision: 12, Authorised, Last updated: 22/11/2022
Ibandronic Acid Teva Cancer Neoplasms Skin … EPAR) for Ibandronic Acid Teva. It explains how the The committee … of use for Ibandronic Acid Teva. What is Ibandronic Acid Teva? Ibandronic Acid Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 13, Withdrawn, Last updated: 30/08/2022
Pioglitazone Teva Pharma Nutritional and Metabolic … Pioglitazone Teva Pharma … statement Pioglitazone Teva Pharma Withdrawal of the … -
List item
Human medicine European public assessment report (EPAR): Mycophenolate mofetil Teva
mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008,, Revision: 25, Authorised, Last updated: 24/06/2022
Mycophenolate mofetil Teva Immune System Phenomena Transplantation … Mycophenolate mofetil Teva … Mycophenolate mofetil Teva 7 Westferry Circus … -
List item
Human medicine European public assessment report (EPAR): Lamivudine/Zidovudine Teva
lamivudine, zidovudine, HIV Infections
Date of authorisation: 28/02/2011,, Revision: 16, Authorised, Last updated: 25/03/2022
Lamivudine/Zidovudine Teva Blood-Borne Infections Communicable … Lamivudine/Zidovudine Teva … Lamivudine/Zidovudine Teva, INN-lamivudine/zidovudine … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva
zoledronic acid, Fractures, Bone; Cancer
Date of authorisation: 16/08/2012,, Revision: 14, Authorised, Last updated: 11/10/2021
Zoledronic acid Teva Wounds and Injuries Cancer Neoplasms Fractures … Zoledronic acid Teva … public Zoledronic acid Teva zoledronic acid This is … -
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva Pharma B.V.
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 01/07/2009,, Revision: 14, Withdrawn, Last updated: 09/07/2021
Ribavirin Teva Pharma B.V. Hepatitis C … Ribavirin Teva Pharma B.V … seven medicines (Cilazapril Teva, Fenofibrato Pensa, Fenofibrato … -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V.
lamivudine, HIV Infections
Date of authorisation: 10/12/2009,, Revision: 18, Authorised, Last updated: 18/01/2022
Lamivudine Teva Pharma B.V. Blood-Borne … Lamivudine Teva Pharma B.V … for the public Lamivudine Teva Pharma B.V. lamivudine This … -
List item
Human medicine European public assessment report (EPAR): Pramipexole Teva
pramipexole dihydrochloride monohydrate, Parkinson Disease
Date of authorisation: 18/12/2008,, Revision: 22, Authorised, Last updated: 23/11/2021
Pramipexole Teva Nervous System Diseases Central … Pramipexole Teva … Pramipexole Teva, INN-pramipexole European … -
List item
Human medicine European public assessment report (EPAR): Imatinib Teva B.V.
imatinib mesilate, Dermatofibrosarcoma; Gastrointestinal Stromal Tumors; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 15/11/2017,, Withdrawn, Last updated: 09/10/2018
Imatinib Teva B.V. Dermatofibrosarcoma Gastrointestinal … Imatinib Teva B.V … Imatinib Teva B.V. imatinib imatinib … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome; Peripheral Vascular Diseases; Myocardial Infarction; Stroke
Date of authorisation: 27/07/2009,, Revision: 18, Authorised, Last updated: 10/06/2022
Clopidogrel Teva (hydrogen sulphate) Cardiovascular … Clopidogrel Teva (hydrogen sulphate … EMEA/H/C/1053 Clopidogrel Teva clopidogrel EPAR summary … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva Pharma
zoledronic acid, Osteoporosis; Osteitis Deformans; Osteoporosis, Postmenopausal
Date of authorisation: 15/08/2012,, Revision: 11, Withdrawn, Last updated: 12/12/2018
Zoledronic acid Teva Pharma Osteoporosis Osteitis … authorisation for Zoledronic acid Teva Pharma has been withdrawn … documents Zoledronic acid Teva Pharma : EPAR - Summary for … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Teva
clopidogrel, acetylsalicylic acid, Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 01/09/2014, Revision: 1, Withdrawn, Last updated: 28/04/2017idogrel/Acetylsalicylic acid Teva Acute Coronary Syndrome Myocardial … Clopidogrel/Acetylsalicylic acid Teva has been withdrawn at the … Clopidogrel / Acetylsalicylic acid Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 19/11/2014, Revision: 2, Withdrawn, Last updated: 31/01/2017Budesonide/Formoterol Teva Pulmonary Disease, Chronic … for Budesonide/Formoterol Teva has been withdrawn at the … documents Budesonide/Formoterol Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva Generics
zoledronic acid monohydrate, Osteoporosis; Osteitis Deformans
Date of authorisation: 27/03/2014,, Revision: 2, Withdrawn, Last updated: 08/08/2016
Zoledronic acid Teva Generics Osteoporosis Osteitis … authorisation for Zoledronic Acid Teva Generics has been withdrawn … documents Zoledronic acid Teva Generics : EPAR - Summary … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva Pharma (previously Clopidogrel HCS)
clopidogrel (as hydrochloride), Myocardial Infarction; Peripheral Vascular Diseases; Stroke
Date of authorisation: 21/09/2009,, Revision: 9, Withdrawn, Last updated: 24/10/2017
Clopidogrel Teva Pharma (previously Clopidogrel … Clopidogrel Teva Pharma (previously Clopidogrel … Public statement Clopidogrel Teva Pharma Withdrawal of the …